Andrea A. Kim
Centers for Disease Control and Prevention
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Andrea A. Kim.
Journal of Acquired Immune Deficiency Syndromes | 2001
Andrea A. Kim; Charlotte K. Kent; Willi McFarland; Jeffrey D. Klausner
&NA; This study evaluated differences in sexual behavior and risk for sexually transmitted diseases (STDs) among men who have sex with men (MSM) who met their partners on‐line and those who did not. A self‐administered questionnaire on sexual behavior was offered to a convenience sample of patients seeking public STD services. Thirty‐two percent of MSM patients reported meeting a sexual partner over the Internet in the past year. MSM with on‐line partners were younger, more likely to report sex with an HIV‐positive person in the last year, and more likely to report casual partners in the last year compared with MSM with only off‐line partners. HIV‐negative MSM with on‐line partners were more likely than HIV‐negative MSM with only off‐line partners to have received money or drugs for sex in the past year and to report sex with an HIV‐positive partner in the past year. Although meeting partners on the Internet was common and associated with increased risk for STDs in MSM, it also presents new untapped opportunities for on‐line health promotion and disease prevention.
PLOS ONE | 2012
Yen T. Duong; Maofeng Qiu; Anindya K. De; Keisha Jackson; Trudy Dobbs; Andrea A. Kim; John N. Nkengasong; Bharat Parekh
Background Accurate and reliable laboratory methods are needed for estimation of HIV-1 incidence to identify the high-risk populations and target and monitor prevention efforts. We previously described a single-well limiting-antigen avidity enzyme immunoassay (LAg-Avidity EIA) to detect recent HIV-1 infection. Methods We describe here further optimization and characterization of LAg-Avidity EIA, comparing it to the BED assay and a two-well avidity-index (AI) EIA. Specimen sets included longitudinal sera (n = 393), collected from 89 seroconverting individuals from 4 cohorts representing 4 HIV-1 subtypes, and sera from AIDS patients (n = 488) with or without TB co-infections from 3 different cohorts. Ninety seven HIV-1 positive specimens were purchased commercially. The BED assay, LAg-Avidity EIA, AI-EIA and HIV serology were performed, as needed. Results Monitoring quality control specimens indicated high reproducibility of the LAg-Avidity EIA with coefficient of variation of <10% in the dynamic range. The LAg-Avidity EIA has an overall mean duration of recency (ω) of 141 days (95% CI 119–160) at normalized optical density (ODn) cutoff of 1.0, with similar ω in different HIV-1 subtypes and populations (132 to 143 days). Antibody avidity kinetics were similar among individuals and subtypes by both the LAg-Avidity EIA and AI-EIA compared to the HIV-IgG levels measured by the BED assay. The false recent rate among individuals with AIDS was 0.2% with the LAg-Avidity EIA, compared to 2.9% with the BED assay. Western blot profiles of specimens with increasing avidity confirm accurate detection of recent HIV-1 infections. Conclusions These data demonstrate that the LAg-Avidity EIA is a promising assay with consistent ω in different populations and subtypes. The assay should be very useful for 1) estimating HIV-1 incidence in cross-sectional specimens as part of HIV surveillance, 2) identifying risk factors for recent infections, 3) measuring impact of prevention programs, and 4) studying avidity maturation during vaccine trials.
Lancet Infectious Diseases | 2009
Rebecca Guy; Judy Gold; Jesus Maria Garcia Calleja; Andrea A. Kim; Bharat Parekh; Michael P. Busch; Thomas Rehle; John W. Hargrove; Robert S. Remis; John M. Kaldor
We systematically reviewed the accuracy of serological tests for recent infections with HIV that have become widely used for measuring population patterns incidence of HIV. Across 13 different assays, sensitivity to detect recent infections ranged from 42-100% (median 89%). Specificity for detecting established infections was between 49.5% and 100% (median 86.8%) and was higher for infections of durations longer than 1 year (median 98%, range 31.5-100.0). For four different assays, comparisons were made between assay-derived population incidence estimates and a reference incidence estimate. The median percentage difference between the assay-derived incidence and reference incidence was 26.0%. Serological assays have reasonable sensitivity for the detection of recent infection with HIV, but are vulnerable to misclassifying established infections as recent-potentially leading to biases in incidence estimates. This conclusion is highly qualified by the apparent absence of a standardised approach to assay evaluation. There is an urgent need for an internationally agreed framework for evaluating and comparing these tests.
AIDS | 2002
Andrea A. Kim; Charlotte K. Kent; Jeffrey D. Klausner
The potential role of sildenafil (Viagra) in the risk of HIV and sexually transmitted disease (STD) transmission was evaluated among gay or bisexual men seeking public STD services in San Francisco. Viagra users reported greater numbers of recent sex partners, higher levels of unprotected anal sex with an HIV-positive partner, and higher rates of prevalent STD than non-users. Moreover, mixing Viagra with illicit drugs was commonly reported. Further studies are needed to determine whether a causal role exists.
Journal of Acquired Immune Deficiency Syndromes | 2010
Tracy Creek; Andrea A. Kim; Lydia Lu; Anna Bowen; Japhter Masunge; Wences Arvelo; Molly Smit; Ondrej Mach; Keitumetse Legwaila; Catherine Motswere; Laurel Zaks; Thomas Finkbeiner; Laura Povinelli; Maruping Maruping; Gibson Ngwaru; Goitebetswe Tebele; Cheryl Bopp; Nancy D. Puhr; Stephanie P. Johnston; Alexandre J Dasilva; Caryn Bern; R S Beard; Margarett Davis
Background:In 2006, a pediatric diarrhea outbreak occurred in Botswana, coinciding with heavy rains. Surveillance recorded a 3 times increase in cases and a 25 fold increase in deaths between January and March. Botswana has high HIV prevalence among pregnant women (33.4% in 2005), and an estimated 35% of all infants under the age of 6 months are not breastfed. Methods:We followed all children <5 years old with diarrhea in the countrys second largest referral hospital at the peak of the outbreak by chart review, interviewed mothers, and conducted laboratory testing for HIV and enteric pathogens. Results:Of 153 hospitalized children with diarrhea, 97% were <2 years old; 88% of these were not breastfeeding. HIV was diagnosed in 18% of children and 64% of mothers. Cryptosporidium and enteropathogenic Escherichia coli were common; many children had multiple pathogens. Severe acute malnutrition (kwashiorkor or marasmus) developed in 38 (25%) patients, and 33 (22%) died. Kwashiorkor increased risk for death (relative risk 2.0; P = 0.05); only one breastfeeding child died. Many children who died had been undersupplied with formula. Conclusions:Most of the severe morbidity and mortality in this outbreak occurred in children who were HIV negative and not breastfed. Feeding and nutritional factors were the most important determinants of severe illness and death. Breastfeeding is critical to infant survival in the developing world, and support for breastfeeding among HIV-negative women, and HIV-positive women who cannot formula feed safely, may prevent further high-mortality outbreaks.
Journal of Acquired Immune Deficiency Syndromes | 2014
Davies Kimanga; Samuel Ogola; Mamo Umuro; Anne Ng’ang’a; Lucy Kimondo; Patrick Murithi; James Muttunga; Wanjiru Waruiru; Ibrahim Mohammed; Shahnaaz Sharrif; Kevin M. De Cock; Frcp; Andrea A. Kim
Background:Enhanced HIV surveillance using demographic, behavioral, and biologic data from national surveys can provide information to evaluate and respond to HIV epidemics efficiently. Methods:From October 2012 to February 2013, we conducted a 2-stage cluster sampling survey of persons aged 18 months to 64 years in 9 geographic regions in Kenya. Participants answered questionnaires and provided blood for HIV testing. We estimated HIV prevalence, HIV incidence, described trends in HIV prevalence over the past 5 years, and identified factors associated with HIV infection. This analysis was restricted to persons aged 15–64 years. Results:HIV prevalence was 5.6% [95% confidence interval (CI): 4.9 to 6.3] in 2012, a significant decrease from 2007, when HIV prevalence, excluding the North Eastern region, was 7.2% (95% CI: 6.6 to 7.9). HIV incidence was 0.5% (95% CI: 0.2 to 0.9) in 2012. Among women, factors associated with undiagnosed HIV infection included being aged 35–39 years, divorced or separated, from urban residences and Nyanza region, self-perceiving a moderate risk of HIV infection, condom use with the last partner in the previous 12 months, and reporting 4 or more lifetime number of partners. Among men, widowhood, condom use with the last partner in the previous 12 months, and lack of circumcision were associated with undiagnosed HIV infection. Conclusions:HIV prevalence has declined in Kenya since 2007. With improved access to treatment, HIV prevalence has become more challenging to interpret without data on new infections and mortality. Correlates of undiagnosed HIV infection provide important information on where to prioritize prevention interventions to reduce transmission of HIV in the broader population.
PLOS ONE | 2011
Reinhard Kaiser; Rebecca Bunnell; Allen W. Hightower; Andrea A. Kim; Peter Cherutich; Mary Mwangi; Tom Oluoch; Sufia Dadabhai; Patrick Mureithi; Nelly Mugo; Jonathan Mermin
Background In order to inform prevention programming, we analyzed HIV discordance and concordance within couples in the Kenya AIDS Indicator Survey (KAIS) 2007. Methods KAIS was a nationally representative population-based sero-survey that examined demographic and behavioral indicators and serologic testing for HIV, HSV-2, syphilis, and CD4 cell counts in 15,853 consenting adults aged 15–64 years. We analyzed interview and blood testing data at the sexual partnership level from married or cohabitating couples. Multivariable regression models were used to identify factors independently associated with HIV discordant and concordant status. Results Of 3256 couples identified in the survey, 2748 (84.4%) had interview and blood testing data. Overall, 3.8% of couples were concordantly infected with HIV, and in 5.8% one partner was infected, translating to 338,000 discordant couples in Kenya. In 83.6% of HIV-infected Kenyans living in married or cohabitating couples neither partner knew their HIV status. Factors independently associated with HIV-discordance included young age in women (AOR 1.5, 95% CI: 1.2–1.8; p<0.0001), increasing number of lifetime sexual partners in women (AOR 1.5, 95% CI: 1.3–1.8; p<0.0001), HSV-2 infection in either or both partners (AOR 4.1, 95% CI: 2.3–7.2; p<0.0001), and lack of male circumcision (AOR 1.6, 95% CI: 1.0–2.5; p = 0.032). Independent factors for HIV-concordance included HSV-2 infection in both partners (AOR 6.5, 95% CI: 2.3–18.7; p = 0.001) and lack of male circumcision (AOR 1.8, 95% CI: 1.0–3.3; p = 0.043). Conclusions Couple prevention interventions should begin early in relationships and include mutual knowledge of HIV status, reduction of outside sexual partners, and promotion of male circumcision among HIV-uninfected men. Mechanisms for effective prevention or suppression of HSV-2 infection are also needed.
Aids and Behavior | 2002
Priscilla Mataure; Willi McFarland; Katherine Fritz; Andrea A. Kim; Godfrey Woelk; Sunanda Ray; George W. Rutherford
We conducted a quantitative and qualitative study of alcohol use and high-risk sexual behavior among adolescents and young adults of age 15–21 years in Harare, Zimbabwe. Methods included a cross-sectional survey of youth sampled at nightclubs and bottle stores informed by participant observation, key informant interviews, and focus group discussions. Findings corroborated a cycle of HIV transmission that involves older men, younger women, and ultimately the steady partners of both. Nightclubs and other drinking establishments catering to youth can provide opportunities for preventing HIV transmission through stuctural interventions or targeted outreach education.
PLOS ONE | 2011
Andrea A. Kim; Timothy B. Hallett; John Stover; Eleanor Gouws; Joshua Musinguzi; Patrick Mureithi; Rebecca Bunnell; John W. Hargrove; Jonathan Mermin; Reinhard Kaiser; Anne Barsigo; Peter D. Ghys
BACKGROUND Several approaches have been used for measuring HIV incidence in large areas, yet each presents specific challenges in incidence estimation. METHODOLOGY/PRINCIPAL FINDINGS We present a comparison of incidence estimates for Kenya and Uganda using multiple methods: 1) Epidemic Projections Package (EPP) and Spectrum models fitted to HIV prevalence from antenatal clinics (ANC) and national population-based surveys (NPS) in Kenya (2003, 2007) and Uganda (2004/2005); 2) a survey-derived model to infer age-specific incidence between two sequential NPS; 3) an assay-derived measurement in NPS using the BED IgG capture enzyme immunoassay, adjusted for misclassification using a locally derived false-recent rate (FRR) for the assay; (4) community cohorts in Uganda; (5) prevalence trends in young ANC attendees. EPP/Spectrum-derived and survey-derived modeled estimates were similar: 0.67 [uncertainty range: 0.60, 0.74] and 0.6 [confidence interval: (CI) 0.4, 0.9], respectively, for Uganda (2005) and 0.72 [uncertainty range: 0.70, 0.74] and 0.7 [CI 0.3, 1.1], respectively, for Kenya (2007). Using a local FRR, assay-derived incidence estimates were 0.3 [CI 0.0, 0.9] for Uganda (2004/2005) and 0.6 [CI 0, 1.3] for Kenya (2007). Incidence trends were similar for all methods for both Uganda and Kenya. CONCLUSIONS/SIGNIFICANCE Triangulation of methods is recommended to determine best-supported estimates of incidence to guide programs. Assay-derived incidence estimates are sensitive to the level of the assays FRR, and uncertainty around high FRRs can significantly impact the validity of the estimate. Systematic evaluations of new and existing incidence assays are needed to the study the level, distribution, and determinants of the FRR to guide whether incidence assays can produce reliable estimates of national HIV incidence.
Sexually Transmitted Diseases | 2003
Andrea A. Kim; Charlotte K. Kent; Jeffrey D. Klausner
Background Rectal gonorrhea in men has been increasing in San Francisco since 1995. Goal The goal was to determine behavioral risk factors associated with rectal gonorrhea (RGC) among men who have sex with men (MSM) by HIV serostatus. Study Design All men reporting receptive anal sex in the last 6 months are screened for RGC, regardless of reported condom use, at San Franciscos municipal sexually transmitted disease (STD) clinic. We surveyed a convenience sample of men screened for RGC at the clinic. Results Among 564 MSM surveyed, 7.1% had RGC. HIV-positive MSM were significantly more likely (relative risk, 3.5, 95% confidence interval, 1.9–5.8) to have RGC. Behavioral risks for RGC infection varied significantly by HIV serostatus. HIV-positive MSM engaging in anonymous sex were at highest risk for RGC infection. Drug use during anal sex was the strongest risk factor for RGC infection among HIV-negative or unknown HIV status MSM. Conclusion Our data suggest that STD and HIV prevention efforts among MSM in San Francisco must consider the role that HIV serostatus plays in acquisition of new infections.